<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">14087</article-id><article-id pub-id-type="doi">10.7554/eLife.14087</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology</subject></subj-group></article-categories><title-group><article-title>Lys29-linkage of ASK1 by Skp1−Cullin 1−Fbxo21 ubiquitin ligase complex is required for antiviral innate response</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-48633"><name><surname>Yu</surname><given-names>Zhou</given-names></name><aff><institution content-type="dept">Zhejiang University School of Medicine</institution>, <institution>Institute of Immunology</institution>, <addr-line><named-content content-type="city">Hangzhou</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-41356"><name><surname>Chen</surname><given-names>Taoyong</given-names></name><aff><institution content-type="dept">Second Military Medical University</institution>, <institution>National Key Laboratory of Medical Immunology and Institute of Immunology</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country><email>chenty@immunol.org</email></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48634"><name><surname>Li</surname><given-names>Xuelian</given-names></name><aff><institution content-type="dept">Second Military Medical University</institution>, <institution>National Key Laboratory of Medical Immunology and Institute of Immunology</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48635"><name><surname>Yang</surname><given-names>Mingjin</given-names></name><aff><institution content-type="dept">Second Military Medical University</institution>, <institution>National Key Laboratory of Medical Immunology and Institute of Immunology</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48636"><name><surname>Tang</surname><given-names>Songqing</given-names></name><aff><institution content-type="dept">Zhejiang University School of Medicine</institution>, <institution>Institute of Immunology</institution>, <addr-line><named-content content-type="city">Hangzhou</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48637"><name><surname>Zhu</surname><given-names>Xuhui</given-names></name><aff><institution content-type="dept">Second Military Medical University</institution>, <institution>National Key Laboratory of Medical Immunology and Institute of Immunology</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48638"><name><surname>Gu</surname><given-names>Yan</given-names></name><aff><institution content-type="dept">Second Military Medical University</institution>, <institution>National Key Laboratory of Medical Immunology and Institute of Immunology</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48639"><name><surname>Su</surname><given-names>Xiaoping</given-names></name><aff><institution content-type="dept">Second Military Medical University</institution>, <institution>National Key Laboratory of Medical Immunology and Institute of Immunology</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48640"><name><surname>Xia</surname><given-names>Meng</given-names></name><aff><institution content-type="dept">Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences</institution>, <institution>National Key Laboratory of Medical Molecular Biology and Department of Immunology</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48641"><name><surname>Li</surname><given-names>Weihua</given-names></name><aff><institution content-type="dept">National Center of Biomedical Analysis</institution>, <institution>Institute of Basic Medical Sciences</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48642"><name><surname>Zhang</surname><given-names>Xuemin</given-names></name><aff><institution content-type="dept">National Center of Biomedical Analysis</institution>, <institution>Institute of Basic Medical Sciences</institution>, <addr-line><named-content content-type="city">Beijing</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-48643"><name><surname>Wang</surname><given-names>Qingqing</given-names></name><aff><institution content-type="dept">Zhejiang University School of Medicine</institution>, <institution>Institute of Immunology</institution>, <addr-line><named-content content-type="city">Hangzhou</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-11686"><name><surname>Cao</surname><given-names>Xuetao</given-names></name><aff><institution content-type="dept">National Key Laboratory of Medical Immunology and Institute of Immunology</institution>, <institution>Zhejiang University School of Medicine</institution>, <addr-line><named-content content-type="city">Hangzhou</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-48644"><name><surname>Wang</surname><given-names>Jianli</given-names></name><aff><institution content-type="dept">Zhejiang University School of Medicine</institution>, <institution>Institute of Immunology</institution>, <addr-line><named-content content-type="city">Hangzhou</named-content></addr-line>, <country>China</country></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1142"><name><surname>Medzhitov</surname><given-names>Ruslan</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Yale University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>04</month><year>2016</year></pub-date><elocation-id>e14087</elocation-id><supplementary-material><ext-link xlink:href="elife-14087-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>28</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>09</day><month>04</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Yu et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Yu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Protein ubiquitination regulated by ubiquitin ligases plays important roles in innate immunity. However, key regulators of ubiquitination during innate response and roles of new types of ubiquitination (apart from Lys48- and Lys63-linkage) in control of innate signaling have not been clearly understood. Here we report that F-box only protein Fbxo21, a functionally unknown component of SCF (Skp1-Cul1-F-box protein) complex, facilitates Lys29-linkage and activation of ASK1 (apoptosis signal-regulating kinase 1), and promotes type I interferon production upon viral infection. Fbxo21 deficiency in mice cells impairs virus-induced Lys29-linkage and activation of ASK1, attenuates c-Jun N-terminal kinase (JNK) and p38 signaling pathway, and decreases the production of proinflammatory cytokines and type I interferon, resulting in reduced antiviral innate response and enhanced virus replication. Therefore Fbxo21 is required for ASK1 activation via Lys29-linkage of ASK1 during antiviral innate response, providing mechanistic insights into non-proteolytic roles of SCF complex in innate immune response.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Xuetao Cao, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health, and was approved by the Scientific Investigation Board of Second Military Medical University, Shanghai (Case No. SMMU-2015-0067).</p></fn></fn-group></back></article>